Back to Journals » ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research
Editor-in-Chief: Professor Giorgio Colombo
An international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (1027)
- Volume 18, 2026 (44)
- Volume 17, 2025 (74)
- Volume 16, 2024 (62)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Latest articles:
- 5 records -
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
Shore N, Lowentritt B, Patel C, Burbage S, Kinkead F, Rossi C, Lee F, Pilon D, Karsh L, Brown G
ClinicoEconomics and Outcomes Research 2026, 18:590934
Published Date: 27 May 2026
Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database
Kieu MTT, Tran DQ, Le ATP, Nguyen HT, Nguyen MC
ClinicoEconomics and Outcomes Research 2026, 18:604685
Published Date: 27 May 2026
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice
Haji Ali Afzali H, Linedale E, Martin C, Ahmed M, Quinlivan J, McPhee AJ, Coates P, Semmler L, Cox D, Gibson RA, Makrides M, Best KP
ClinicoEconomics and Outcomes Research 2026, 18:585692
Published Date: 26 May 2026
The Socioeconomic Impact of Long-Acting Injectable Buprenorphine
Rasche SE, Batchelor GOW, Montgomery C, Sumnall HR, Mogford D
ClinicoEconomics and Outcomes Research 2026, 18:590462
Published Date: 20 May 2026
Nivolumab-AVD versus Brentuximab Vedotin-AVD as First-Line Treatment for Advanced-Stage Classical Hodgkin Lymphoma: A Cost-Effectiveness Analysis
Li B, Yang J, Li J, Huang J, Li Z
ClinicoEconomics and Outcomes Research 2026, 18:590836
Published Date: 19 May 2026